Rockefeller Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-200
| Closed | -$1K | – | 2558 |
|
|
2022
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 3674 |
|
|
2022
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 3704 |
|
|
2022
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 3940 |
|
|
2022
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 3917 |
|
|
2021
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 3630 |
|
|
2021
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 3425 |
|
|
2021
Q2 | $4K | Sell |
200
-500
| -71% | -$10K | ﹤0.01% | 3080 |
|
|
2021
Q1 | $19K | Buy |
700
+500
| +250% | +$13.6K | ﹤0.01% | 2299 |
|
|
2020
Q4 | $5K | Hold |
200
| – | – | ﹤0.01% | 2424 |
|
|
2020
Q3 | $7K | Hold |
200
| – | – | ﹤0.01% | 2109 |
|
|
2020
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 1893 |
|
|
2020
Q1 | $6K | Hold |
200
| – | – | ﹤0.01% | 1888 |
|
|
2019
Q4 | $12K | Buy |
+200
| New | +$12K | ﹤0.01% | 1555 |
|